Inventor · disambiguated record
Nicole Diedrichs
Also filed as: DIEDRICHS NICOLE
15 granted patents·9 pending applications·322 citations·filing 2002–2015
93Inventor score
Technology areasA61P
Files withBAYER SCHERING PHARMA AG5BAYER AG3BAYER HEALTHCARE AG3BAYER IP GMBH3BAYER HEALTHCARE AG LAW AND PA1
Top patents by PatentIndex Score
24 records- 0193US7109218B2Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the sameBAYER HEALTHCARE AG·Filed 2002·Granted Sep 19, 2006·61 cites·8 claims
- 0292US7709504B2Use of Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines in the treatment of nausea and vomitingBAYER SCHERING PHARMA AG·Filed 2005·Granted May 4, 2010·27 cites·4 claims
- 0392US7078417B2Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines with adenosine receptor-binding activity and their use as cardiovascular preparationsBAYER AG·Filed 2002·Granted Jul 18, 2006·59 cites·8 claims
- 0492US7045631B2Substituted 2-thio-3, 5-dicyano-4-phenyl-6-aminopyridines and their use as adenosine receptor-selective ligandsBAYER AG·Filed 2002·Granted May 16, 2006·53 cites·6 claims
- 0591US7129255B2Substituted 2-carba-3,5-dicyano-4-aryl-6-aminopyridines and the use of the same as selective ligands of the adenosine receptorBAYER AG·Filed 2002·Granted Oct 31, 2006·55 cites·6 claims
- 0686US7855219B2Substituted 2-oxy-3,5-dicyano-4aryl-6-aminopyridines and use thereofBAYER SCHERING PHARMA AG·Filed 2002·Granted Dec 21, 2010·26 cites·5 claims
- 0783US8242281B2Substituted 2, 6-diamino-3, 5-dicyano-4-arylpyridines and their use as adenosine-receptor-selective ligandsROSENTRETER ULRICH·Filed 2006·Granted Aug 14, 2012·6 cites·5 claims
- 0882US7825255B2Adenosine receptor selective modulatorsBAYER SCHERING PHARMA AG·Filed 2002·Granted Nov 2, 2010·18 cites·5 claims
- 0980US8703696B2Dipeptoid prodrugs and the use thereofLERCHEN HANS-GEORG·Filed 2008·Granted Apr 22, 2014·3 cites·8 claims
- 1074US8957017B2Dipeptoid prodrugs and their useBAYER IP GMBH·Filed 2014·Granted Feb 17, 2015·1 cites·7 claims
- 1174US8703934B2Substituted 4-amino-3,5-dicyano-2-thiopyridines and use thereofNELL PETER·Filed 2007·Granted Apr 22, 2014·2 cites·6 claims
- 1273US7615557B2Tetrahydro-naphthalene and urea derivativesXENTION LTD·Filed 2004·Granted Nov 10, 2009·9 cites·26 claims
- 1371US8030347B2Cylopenta[b]benzofuran derivatives and the utilization thereofBAYER HEALTHCARE AG·Filed 2005·Granted Oct 4, 2011·2 cites·15 claims
- 1454US2013040992A1Substituted 2, 6-Diamino-3, 5-Dicyano-4-Aryl-Pyridines And Their Use As Adenosine-Receptor-Selective LigandsBAYER IP GMBH·Filed 2012·Application pending·0 cites
- 1552US7683076B2Tetrahydro-quinolinylurea derivativesBAYER SCHERING PHARMA AG·Filed 2004·Granted Mar 23, 2010·0 cites·15 claims
- 1652US2006217373A1Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the sameBAYER HEALTHCARE AG·Filed 2006·Application pending·0 cites
- 1750US2004162427A1Substituted 2,6-diamino-3,5-dicyano-4-aryl-pyridines and their use as adenosine receptor-selective ligandsFiled 2002·Application pending·0 cites
- 1849US2012122820A1Prodrugs and the use thereofDIEDRICHS NICOLE·Filed 2008·Application pending·0 cites
- 1947US2015133364A1Dipeptoid prodrugs and their useBAYER IP GMBH·Filed 2015·Application pending·0 cites
- 2045US2016311812A1Adenosine a1 agonists as medicaments for kidney disordersBayer Pharma AG·Filed 2014·Application pending·0 cites
- 2143US2008045546A1Tetradydro-Naphthalene And Urea DerivativesBOUCHON AXEL·Filed 2004·Application pending·0 cites
- 2243US2010048641A1Use of Adenosine A1 and/or Dual A1/2ab Agonists for Production of Medicaments for Treating DiseasesBAYER HEALTHCARE AG LAW AND PA·Filed 2007·Application pending·0 cites
- 2341US2010137361A1Tetrahydro-Quinolinylurea DerivativesBAYER SCHERING PHARMA AG·Filed 2010·Application pending·0 cites
- 2435US8691850B2Substituted phenylaminothiazoles and use thereofERGUEDEN JENS-KERIM·Filed 2005·Granted Apr 8, 2014·0 cites·4 claims
Join the waitlist — get patent alerts
Get an alert when Nicole Diedrichs files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →